Skip to main content

Advertisement

Log in

Glycopeptide and daptomycin resistance in community-associated MRSA in the UK

  • Correspondence
  • Published:
Infection Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Millar BC, Prendergast BD, Moore JE. Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis. J Antimicrob Chemother. 2008;61(1):1–7.

    Article  PubMed  CAS  Google Scholar 

  2. Andrews JM. BSAC standardized disc susceptibility testing method (version 7). J Antimicrob Chemother. 2008;62(2):256–78.

    Article  PubMed  CAS  Google Scholar 

  3. Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29(5):1128–32.

    Article  PubMed  CAS  Google Scholar 

  4. Shutt CK, Pounder JI, Page SR, Schaecher BJ, Woods GL. Clinical evaluation of the DiversiLab microbial typing system using repetitive-sequence-based PCR for characterization of Staphylococcus aureus strains. J Clin Microbiol. 2005;43(3):1187–92.

    Article  PubMed  CAS  Google Scholar 

  5. Ellington MJ, Perry C, Ganner M, Warner M, McCormick Smith I, Hill RL, et al. Clinical and molecular epidemiology of ciprofloxacin-susceptible MRSA encoding PVL in England and Wales. Eur J Clin Microbiol Infect Dis. 2009;28(9):1113–21.

    Article  PubMed  CAS  Google Scholar 

  6. Murchan S, Kaufmann ME, Deplano A, de Ryck R, Struelens M, Zinn CE, et al. Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains. J Clin Microbiol. 2003;41(4):1574–85.

    Article  PubMed  CAS  Google Scholar 

  7. Perichon B, Courvalin P. VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2009;53(11):4580–7.

    Article  PubMed  CAS  Google Scholar 

  8. van Hal SJ, Paterson DL, Gosbell IB. Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naive patient—a review of the literature. Eur J Clin Microbiol Infect Dis. 2010. doi:10.1007/s10096-010-1128-3

  9. van Hal SJ, Paterson DL. Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates. Antimicrob Agents Chemother. 2011;55(1):405–10.

    Article  PubMed  Google Scholar 

  10. Wootton M, Howe RA, Hillman R, Walsh TR, Bennett PM, MacGowan AP. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J Antimicrob Chemother. 2001;47(4):399–403.

    Article  PubMed  CAS  Google Scholar 

  11. Moise PA, North D, Steenbergen JN, Sakoulas G. Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions. Lancet Infect Dis. 2009;9(10):617–24.

    Article  PubMed  CAS  Google Scholar 

  12. Tsuji BT, Rybak MJ, Cheung CM, Amjad M, Kaatz GW. Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents. Diagn Microbiol Infect Dis. 2007;58(1):41–7.

    Article  PubMed  CAS  Google Scholar 

  13. Hageman JC, Patel J, Franklin P, Miscavish K, McDougal L, Lonsway D, et al. Occurrence of a USA300 vancomycin-intermediate Staphylococcus aureus. Diagn Microbiol Infect Dis. 2008;62(4):440–2.

    Article  PubMed  CAS  Google Scholar 

  14. Graber CJ, Wong MK, Carleton HA, Perdreau-Remington F, Haller BL, Chambers HF. Intermediate vancomycin susceptibility in a community-associated MRSA clone. Emerg Infect Dis. 2007;13(3):491–3.

    Article  PubMed  CAS  Google Scholar 

  15. Patel JB, Jevitt LA, Hageman J, McDonald LC, Tenover FC. An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus. Clin Infect Dis. 2006;42(11):1652–3.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The subject of this report gave written informed consent approving its publication. This study was funded by the University of Liverpool.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Kirby.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kirby, A., Edwards, C., Broughton, C.M. et al. Glycopeptide and daptomycin resistance in community-associated MRSA in the UK. Infection 39, 277–279 (2011). https://doi.org/10.1007/s15010-011-0103-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-011-0103-y

Keywords

Navigation